Showing 1–17 of 17 results
-
Research |
Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy
- J Gauthier
- , L Castagna
- , F Garnier
- , T Guillaume
- , G Socié
- , S Maury
- , N Maillard
- , R Tabrizi
- , T Marchand
- , J Malfuson
- , A Gac
- , E Gyan
- , M Mercier
- , Y Béguin
- , J Delage
- , P Turlure
- , A Marçais
- , S Nguyen
- , R Dulery
- , J Bay
- , A Huynh
- , E Daguindau
- , J Cornillon
- , C Régny
- , M Michallet
- , R Peffault de Latour
- , I Yakoub-Agha
- & D Blaise
Bone Marrow Transplantation 52 , 689–696 -
Research |
-
Research |
Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
- A-C Mamez
- , V Lévy
- , P Chevallier
- , D Blaise
- , S Vigouroux
- , A Xhaard
- , N Fegueux
- , N Contentin
- , Y Beguin
- , N Ifrah
- , C-E Bulabois
- , F Suarez
- , I Yakoub-Agha
- , P Turlure
- , E Deconink
- , T Lamy
- , J Y Cahn
- , A Huynh
- , S Maury
- , L M Fornecker
- , M Ouzegdouh
- , J-O Bay
- , G Guillerm
- , N Maillard
- , M Michallet
- , J-V Malfuson
- , J-H Bourhis
- , F Rialland
- , R Oumedaly
- , C Jubert
- , V Leblond
- , M Boubaya
- , M Mohty
- & S Nguyen
Bone Marrow Transplantation 51 , 358–364 -
-
Research |
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT
- S P Robinson
- , C Canals
- , J J Luang
- , H Tilly
- , C Crawley
- , J Y Cahn
- , D Pohlreich
- , S Le Gouill
- , M Gilleece
- , N Milpied
- , M Attal
- , P Biron
- , S Maury
- , A Rambaldi
- , J Maertens
- , S Capria
- , P Colombat
- , S Montoto
- & A Sureda
Bone Marrow Transplantation 48 , 1409–1414 -
-
Research |
-
Research |
-
-
Research |
-
-
Research |
High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia
- D Rea
- , L Legros
- , E Raffoux
- , X Thomas
- , P Turlure
- , S Maury
- , B Dupriez
- , A Pigneux
- , B Choufi
- , O Reman
- , D Stéphane
- , B Royer
- , M Vigier
- , M Ojeda-Uribe
- , C Recher
- , H Dombret
- , F Huguet
- & P Rousselot
Leukemia 20 , 400–403 -
Research |
-
-
-
Research |
-
Research |
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord
- S Nguyen
- , A Achour
- , L Souchet
- , S Vigouroux
- , P Chevallier
- , S Furst
- , A Sirvent
- , J-O Bay
- , G Socié
- , P Ceballos
- , A Huynh
- , J Cornillon
- , S Francois
- , F Legrand
- , I Yakoub-Agha
- , G Michel
- , N Maillard
- , G Margueritte
- , S Maury
- , M Uzunov
- , C-E Bulabois
- , M Michallet
- , L Clement
- , C Dauriac
- , K Bilger
- , J Lejeune
- , V Béziat
- , V Rocha
- , B Rio
- , S Chevret
- & V Vieillard
Bone Marrow Transplantation 52 , 1428–1435
